[Data] The National Health and Safety Commission's clinical inspection center released: Which is strong in China's genetic testing?

Recently, the Clinical Testing Center of the Ministry of Health of the People's Republic of China issued the "National Tumor Diagnosis and Treatment High-throughput Sequencing Detection (Embrane Mutation) Inter-Range Quality Evaluation Survey Results Report", a total of 60 laboratories submitted results. The effective result is 44 copies. The report published a list of 34 participating laboratories that passed the inter-room quality evaluation activity.

The full list of labs is as follows:

National Interventional Evaluation and Treatment of High-throughput Sequencing (somatic mutations and germline mutations) inter-unit quality assessment and scoring principles of formal quality assessment

Laboratory quality assurance is important for any testing program, such as laboratory design, standard operating procedures, indoor quality control, performance verification and performance evaluation of reagent methods, personnel training, etc., which are effective for individual laboratories. The accuracy and repeatability of the results. In the quality assessment of somatic mutation testing, a large number of false positive and false negative results in the laboratory fully demonstrate that there are still many areas for improvement in laboratory testing.

However, for high-throughput sequencing of tumor diagnosis and treatment, it is important to ensure the comparability of test results in each laboratory. It may be important to standardize the classification and definition of different clinical significance of somatic mutations and germline mutations.

Non-locking Plate

Non-Locking Plate

Non-Locking Plate,Non-Locking Orthopedic Plate,Titanium Olecranon Plates,Humerus Distal Plates

Medton Medical , https://www.medton.cn